Drug intelligence / Profile preview

Jiejing Runmu decoction

Development stage: Unknown
Administration: Oral

Overview

Jiejing Runmu decoction is a traditional Chinese medicine (TCM) herbal formula used for the treatment of dry eye disease. It is administered as a decoction, typically taken orally once daily. In a prospective clinical study, this formula was shown to significantly improve both subjective symptoms and objective signs in patients with dry eye disease over a 4-week course, with continued improvement at follow-up. Mechanistic details are not explicitly described in the literature, but TCM formulas for dry eye often aim to nourish yin, moisten dryness, and promote tear secretion. The decoction was well tolerated, with no significant adverse effects reported in the clinical study.

Brand names: Jiejing Runmu decoction
Other names: Jiejing Runmu decoction

Beyond the preview

Go deeper on Jiejing Runmu decoction.

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from study design and recruitment through results.

Trial phase
Status
Readouts

Indications & development

Explore development by indication, patient population, and geography.

Indications
Development status
Countries

Licensing & deals

Trace asset ownership, licensing agreements, and commercial partnerships.

Partners
Deal terms
Milestones

Patents & exclusivity

Explore the patent landscape and regulatory exclusivity around an asset.

Patents
Expiration dates
Exclusivity

Competitive landscape

Compare development programs by target, modality, and indication.

Competing assets
Targets
Development stage

Research & analysis

Connect source evidence and development news to your research questions.

Publications
News
Analysis

Bring the full picture into focus.

See how Gosset can support your research on Jiejing Runmu decoction.

Explore the full profile